AngioDynamics Presents at American Venous Forum
AngioDynamics recently attended the 22nd annual meeting of the American Venous Forum (AVF), which brings together internationally recognized authorities on all aspects of venous disease, diagnosis, pathophysiology and treatment. The meeting attracted more than 350 general surgeons, vascular surgeons, interventional radiologists, physician assistants, nurse practitioners and other medical professionals who specialize in venous disease. The primary objective of AVF is to educate attendees on current thinking in effective clinical management of venous disease and offer insight into the future directions from critical analysis of investigative findings.
As a recognized leader in the field, AngioDynamics was invited to participate and David Doster, Senior Product Manager of venous products, presented “Technologies of the Future: What do We Need and Where are We Going?” to approximately 200 attendees. In his presentation, David discussed venous disease ten years ago, how it has increased, and the future of technology in treating venous disease. He also discussed key market drivers, such as innovation, high growth markets, reimbursement and patient awareness. David commented, “It was an honor to present to the world’s foremost thought leaders in the treatment field of venous disease. Venous disease affects an estimated one out of every five adults and it’s exciting to know that our products and future innovation have the potential to positively affect so many people.”
After the meeting, Dr. Peter Pappas, president of the American Venous Forum, wrote “I thought it vitally important to hear the perspective of industry leaders such as AngioDynamics, and how physicians and professional societies can impact this process. David's talk was extremely well presented, and he established the foundation for the speakers that followed him. I knew that having an industry representative provide this talk would preclude registrants for this entire session from receiving CME credits. Despite this fact, I thought the information provided was so valuable that the benefit of disseminating his thoughts outweighed the lack of CMEs for this event. I would like to personally thank David and AngioDynamics for participating in the post-graduate course, and I look forward to our future collaborations.”